New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...

In recent years, the story around HIV has shifted dramatically. What was once viewed as a life sentence is now increasingly seen as a manageable condition. Medication is responsible for much of that ...

Although adolescents and young adults comprise only one quarter of the sexually active population in the United States, ...

Thousands in Florida who rely on the AIDS Drug Assistance Program will see their coverage cut or their medication changed, ...

Until last year, the number of children orphaned because a parent died from AIDS, was plummeting. That's thanks to America's 20 year effort to get lifesaving HIV meds to millions in need. But last ...

PROVIDENCE – Infectious disease doctors and public health advocates are raising concerns as Harvard Pilgrim, a health insurance provider, plans to phase out coverage of several HIV treatments next ...